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Abstract Our previous study assessed the prevalence of
ﬁbromyalgia (FM) syndrome in migraine and tension-type
headache. We aimed to update our previous results, con-
sidering a larger cohort of primary headache patients who
came for the ﬁrst time at our tertiary headache ambulatory.
A consecutive sample of 1,123 patients was screened.
Frequency of FM in the main groups and types of primary
headaches; discriminating factor for FM comorbidity
derived from headache frequency and duration, age, anxi-
ety, depression, headache disability, allodynia, pericranial
tenderness, fatigue, quality of life and sleep, and proba-
bility of FM membership in groups; and types of primary
headaches were assessed. FM was present in 174 among a
total of 889 included patients. It prevailed in the tension-
type headache main group (35%, p\0.0001) and chronic
tension-type headache subtype (44.3%, p\0.0001).
Headache frequency, anxiety, pericranial tenderness, poor
sleep quality, and physical disability were the best dis-
criminating variables for FM comorbidity, with 81.2%
sensitivity. Patients presenting with chronic migraine and
chronic tension-type headache had a higher probability of
sharing the FM proﬁle (Bonferroni test, p\0.01). A
phenotypic proﬁle where headache frequency concurs with
anxiety, sleep disturbance, and pericranial tenderness
should be individuated to detect the development of diffuse
pain in headache patients.
Keywords Primary headache  Fibromyalgia 
Comorbidity
Introduction
According to the American College of Rheumatology
(ACR), ﬁbromyalgia (FM) is a chronic pain syndrome of
unknown aetiology, characterized by diffuse pain for more
than 3 months and tenderness in at least 11 tender point
sites out of 18 [1]. Despite these apparently simple diag-
nostic criteria, the syndrome appears more complex with
associated symptoms including non-restorative sleep, fati-
gue, and cognitive dysfunction [2].
Causes of FM are largely unknown although there is a
growing body of evidence to support central sensitization
mechanism underlying chronic musculoskeletal pain in
these patients [3]. Although the association between FM
and primary headaches is almost frequent, rheumatologists
have classiﬁed it as ‘‘an unexplained clinical condition’’ [4].
FM comorbidity was specially studied in migraine pop-
ulation, with a prevalence of 35.6% in patients with trans-
formed migraine [5] and 22% in episodic migraine patients
[6]. In our cohort of 217 consecutive headache patients,
36.4% of the patients were found to have FM [7]. FM was
the most common among chronic migraine and chronic
tension-type headache patients. Headache frequency, peri-
cranial muscle tenderness, anxiety, and sleep inadequacy
were especially associated with FM comorbidity. Tension-
type headache was the most common primary headache
associated with FM, with a 59.01% prevalence, compared
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prevalence. There was no difference between chronic ten-
sion-type headache and chronic migraine in FM syndrome
prevalence; this suggests that FM is a syndrome compli-
cating these two types of chronic headaches. On the other
hand, headache is common among the patients with FM. In
a study of 100 patients with FM, recurring headache
occurred in 76%, and predated the onset of FM, on average,
7 years before the onset of FM symptoms [8]. Similarly, in
a study of 33 FM patients, current migraine was present in
45% and a lifetime history of migraine in 55% [9].
The mutual comorbidity between headache and FM
reserves much attention, in view of common pathophysi-
ological basis [10] and problems connected with thera-
peutical approach [11].
In addition, there are still unresolved questions, e.g. the
prevalence of FM in other primary-headache forms, as
trigeminal autonomic cephalalgias (TACs), and the factors
favouring FM comorbidity. We aimed to extend our study
[7] to a larger sample selected during a total observational
period of 2 years at our tertiary headache centre, to check
the validity of previously observed prevalence of FM
comorbidity and to characterize the features of patients
sharing headache and FM syndrome and their representa-
tion within main headache groups and types, in an attempt
to give further details on FM comorbidity in less common
forms of primary headaches.
Methods
Following previous evaluation from 1 January 2007 to 30
June 2007, where a total of 274 patients were screened and
217 were included [7], we screened further 849 consecutive
outpatients, who came for the ﬁrst time at the Neurophys-
iopathology of Pain Unit (Neurological and Psychiatric
Sciences Department, Bari University) from 1 July 2007 to
30 December 2009. The Neurophysiopathology of Pain
Unit is a tertiary referral centre where patients are referred
by primary physicians as well as by neurological and other
specialty clinics. All participants gave written informed
consent after receiving a detailed explanation of the purpose
and design of the study. The study was approved by the
local Ethics Committee of the Policlinico General Hospital.
According to the previous study [7], during the ﬁrst
visit, all subjects had a standardized interview and under-
went clinical neurological and psychiatric examination.
The inclusion criteria was a diagnosis of primary headache
made by three neurologists with special experience in
headache, according to the International Classiﬁcation of
Headache Disorders, 2nd edn (ICHD-II) criteria [12], and
was supported by a 3-month observation time with a
headache diary and allodynia questionnaire.
The inclusion/exclusion criteria and clinical manage-
ment of patients were the same as the previous study [7].
Brieﬂy, patients with general medical, neurological or
psychiatric diseases [13], were excluded from the study, as
well as the patients on central nervous system-active drug
therapy to rule out any drug effect on diffuse pain. A par-
ticular attention was taken in screening out patients suf-
fering from various conditions with diffuse pain, such as
arthritis, diabetes or other metabolic causes of neuropathic
pain. We included other types of primary headaches, and in
the case of hemicrania continua (code. 4.7) [12], the
3 months preceding the ﬁrst visit were considered for
headache features and FM comorbidity, to prescribe in-
domethacine and conﬁrm the diagnosis in the next control.
During the follow-up visit (except for patients with
hemicrania continua, who were examined during their ﬁrst
visit, and the diagnosis conﬁrmed at the follow-up), all
patients underwent the clinical assessment, deﬁned in the
previous study [7], consisting of evaluation for FM diag-
nosis and tender point count [1], frequency of headache [7],
total tenderness score (TTS) [14], allodynia questionnaire
[15, 16], Short-Form 36 (SF-36) Health Survey [17],
depression [self-rating depression scale (SDS)] and anxiety
[self-rating anxiety scale (SAS)] scales [18, 19], Multidi-
mensional Assessment of Fatigue (MAF) [20], and Medical
Outcomes Study (MOS) [21]. In this study, we considered
the sleep problems index (SLP9), expressing the sleep
problems index, and Sleep quantity (SLPQ), expressing the
sleep quantity [21].
Migraine Disability Assessment scale (MIDAS) [22], in
the Italian version [23], was used to quantify headache-
related disability in all headache patients, differently from
the preliminary study [7]; the MIDAS score was considered
only for migraine groups.
Patients presenting with FM comorbidity, according
to the ACR criteria [1], were submitted for the Manual
Tender Point Survey, [24–26] and answered the FM
Impact Questionnaire (FIQ) [27], in accord with the pre-
vious study [7].
Statistical analysis
All patients were included in headache major groups,
according to the main ICHD-II codex [12], where we did
not include the mixed forms. Within each major group, the
type of headache was further speciﬁed, and subgroups
including at least ten patients were considered. The fre-
quency of FM across main headache groups and types was
checked by means of the Pearson’s Chi-square as well as
the distribution of FM comorbidity between genders. The
clinical variables such as age, headache frequency and
duration, allodynia, SAS, SDS, MAF, MIDAS, SLP9,
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(MANOVA) with type III sum of square where the
comorbidity for FM was the main factor. The least sig-
niﬁcant difference (LSD) was applied to the conﬁdence
intervals of the single variables. To ﬁnd the best separating
variables between FM and non-FM groups, a stepwise
discriminant analysis was run, using Mahalanobis distance,
F probability of 0.05 for entry and 0.1 for removal, clas-
siﬁcation function coefﬁcient by means of Fisher’s linear
discriminant test, and leaving one out of ﬁnal classiﬁcation.
To further specify if a speciﬁc group or type of headache
shared the clinical proﬁle of FM, the function coefﬁcient
was then employed to attribute to each patient the proba-
bility of membership to the FM group. The Bonferroni test
for multiple comparisons was used to detect the main dif-
ferences of FM probabilities across headache groups and
types. We further evaluated if there was a correlation
between the gravity of headache, expressed by MIDAS,
frequency, allodynia, and TTS; and the severity of FM
symptoms, expressed by the FIQ and total tender point
survey score, by means of the Pearson’s correlation test.
All statistics were done applying the SPSS version 8.
Results
Among a total of 1,123 patients who came for the ﬁrst time
to our centre, we included 889 consecutive patients (204
men). The remainder 224 were not included for various
reasons; 24 [3 cluster headache, 1 migraine with aura
(MA), 20 chronic migraine] needed to start or modify the
preventive treatment as soon as possible; a very invali-
dating headache or various familiar or social circumstances
did not enable the 3 months observation. Two patients
were pregnant, 50 patients were affected by secondary
headaches, 100 did not pass the inclusion criteria for var-
ious reasons, as psychiatric or general medical comorbid-
ities or CNS acting drugs intake, the remainder were lost to
follow-up or did not apply to diary compilation.
All patients were included in four headache major
groups, according to the main ICHD-II codex [12]
(Table 1). To understand if FM comorbidity involved
preferentially a form of primary headache, in this subdi-
vision we did not consider mixed forms across different
headache major groups. Within each major group, the type
of headache was further speciﬁed, and subgroups including
at least ten patients were considered. We obtained ten
headache types subgroups, with an eleventh mixed-type
group (Table 2).
In Table 3, the main clinical features of each head-
ache type are reported. Considering the main headache
groups, FM prevailed in tension-type headache, followed
by migraine group (Table 1). Considering the primary
headache types, FM was specially represented in chronic
tension-type headache, followed by chronic migraine
(Table 2). Among FM patients, 13 were men (7.4% of all
the FM patients, vs. 22.94%) in the entire headache pop-
ulation (Pearson’s Chi-square 29.38; df 1, p 0.0001). The
whole considered variables signiﬁcantly distinguished
headache patients from those without FM comorbidity
(results of MANOVA: F = 21.41, error df 875; df 13,
p 0.0001). Allodynia symptoms and total hours of sleep
were not signiﬁcantly different between patients presenting
and not presenting with FM comorbidity (Table 4).
The stepwise discriminant analysis found that the best
discriminating variables for FM comorbidity were fre-
quency of headache, anxiety levels, TTS, sleep distur-
bances, and physical component of life quality (Table 5).
The canonical discriminant function, correctly classiﬁed
81.2% of the original grouped cases and 80.5% of the cross-
validated grouped cases (Fig. 1).
The probability of membership to FM group did not
differ signiﬁcantly across the main headache groups, while
both chronic migraine and chronic tension-type headache
patients exhibited the highest and MA patients the lowest
levels of probability (Fig. 2).
The FIQ was positively correlated with frequency of
headache, MIDAS score, and allodynia, while pain at the
tender points was correlated with TTS and frequency of
headache (Table 6).
Discussion
Frequency of FM comorbidity in headache groups
and types
In this study, which is the extension of the previous one in
a smaller headache series [7], we found a lower frequency
of FM representation in the selected patients. Other studies
on this topic were specially dedicated to chronic or epi-
sodic migraine without aura (MWA), with a reported fre-
quency, respectively, of 35 and 22% in the selected
populations [5, 6]. A recent multicentre study on 1,413
patients [28], reported 10% of migraine patients presenting
with FM comorbidity, but the features of migraine were not
speciﬁed. The frequency of 17.8% that we actually found
in the migraine group was almost the same as the previous
report [7], with a minimum in purely MA and a maximum
in chronic migraine. The apparent discordance of FM
prevalence across studies may be due to variability in
applying FM diagnostic criteria, or the uncertainness of a
story of widespread pain reported from patients who came
to visit for another reason. The FM diagnostic criteria are
not devoid of problems, and the ACR has proposed to
enlarge the symptoms useful for diagnosis [29], applying
J Headache Pain (2011) 12:629–638 631
123clinical criteria based on fatigue, cognitive symptoms, and
the extent of somatic symptoms, without considering the
number of positive tender points. These new criteria would
be easily applied in headache centre and facilitate the
detection of FM comorbidity. Interestingly, FM comor-
bidity was absent in patients presenting exclusively with
MA attacks. This is a new data, given that in the study by
Ifergane et al. [6] and Tietjen et al. [28], the presence of
aura was reported without specifying the contemporary
occurrence of MWA attacks. In the present study, patients
with both MA and MWA diagnosis had the same FM
frequency as those without aura, while it seemed that it was
the exclusive presence of MA attacks to preserve from FM
comorbidity. These data need to be conﬁrmed in larger
series, and may be supported by a pathophysiological
explanation, as also supposed below. No studies are
available on FM prevalence in the other forms of primary
headache. Even in tension-type headache, where growing
evidences indicate common pathophysiological basis with
FM, only single cases of comorbidity are reported [30–34].
In our study, according to the previous one [7], tension-
type headache showed the major FM representation among
primary headaches, with 35.1% prevalence. In FM popu-
lations, both migraine and tension-type headache are con-
sidered among the main causes of comorbidity [4]. The
present results indicate a 25% frequency of FM in migraine
and tension-type headache groups, not largely dissimilar
from our preliminary study [7], in accord with which the
chronic forms share the highest FM representation. This
may also partly explain the preponderance of patients
associating tension-type headache and generalized pain,
given that in the tension-type group, most of the patients
were chronic. It was the low representation of FM patients
in the other primary headache groups (TACs and other
forms) that reduced the FM frequency found in the total
headache sample. For hemicrania continua, the retrospec-
tive evaluation used to prescribe indomethacine for con-
ﬁrming diagnosis after the observational period, may have
induced an underestimation of FM comorbidity, with
respect to the other considered headache types. Also, tak-
ing into consideration the low number of patients included
in groups three and four of primary headaches, no
Table 1 Frequency of
ﬁbromyalgia (FM) comorbidity
in the primary headache groups
Pearson chi square: 34.77, df 3,
p 0.0001
No FM (no.) FM (no.)
Main ICHD II group
Cod 1.00 migraine 521 113
Cod 2.00 tension-type headache 100 54
Cod. 3.00 cluster headache and other TACs 24
Cod.4.00 other primary headaches 35 2
Total 680 (80.1%) 169 (19.9%)
Table 2 Frequency of
ﬁbromyalgia comorbidity (FM)
in the primary headaches types
Pearson chi square: 96.92, df 10,
p 0.0001
Primary headache type No FM (no.) FM (no.)
Chronic migraine cod.1.5.1 88 53
Chronic tension-type headache cod 2.3 54 43
Cluster headache cod 3.1 13
Episodic frequent tension type headache cod 2.2 46 9
Hemicrania continua cod 4.7 12 1
Migraine with aura cod 1.2 20
Migraine with aura plus migraine without aura cod 1.1 plus 1.2 35 6
Migraine without aura cod 1.1 377 55
Migraine without aura plus frequent episodic tension type
headache cod 1.1 plus 2.2
36 6
Mixed headache types
Primary stabbing headache no. 7 cod 4.1 23 1
Primary thunderclap headache no. 1 cod 4.6
Hypnic headache no. 8 cod 4.5
Primary cough headache no. 4 cod 4.2
Primary exertional headache no. 3 cod 4.3
Paroxysmal hemicrania cod 3.2 11
Total 715 (80.43%) 174 (19.57%)
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123deﬁnitive conclusion about FM comorbidity could be
made, rather an impression of a low FM representation
even in types with high headache frequency was found. In
this sense, the frequency of headache should be the main
but not the exclusive factor favouring FM, as speciﬁed
below.
Factors favouring FM comorbidity
The phenotype expression of headache patients complain-
ing with FM comorbidity included higher headache fre-
quency, anxiety, pericranial tenderness, reduced physical
performances, and sleep disturbances. Allodynia, which
expresses the severity of central sensitization occurring
during headache episodes [38], was not signiﬁcantly
increased in our FM series, suggesting that central sensiti-
zation should persist outside acute headache and generate
myofascial pain to favour FM comorbidity. As expected,
women prevailed in the FM group, as FM is six times more
common in women, while headache and specially migraine
is three times more common. The cycle phase would also
inﬂuence pericranial and somatic tender points sensitivity
[39], though in the present study this aspect was not taken
into consideration. This is a conﬁrmation of discriminating
features of FM previously detected in a smaller headache
series [7] with the inclusion of physical component of
quality of life. Chronic migraine and chronic tension-type
headache subtypes shared this headache proﬁle in a sig-
niﬁcant way with respect to the other forms, conﬁrming
headache frequency as the primary factor for FM comor-
bidity. Pericranial tenderness is considered as a conse-
quence of chronic headache [36, 37], as a sign of permanent
sensitization at cervical and trigeminal second-order noci-
ceptive neurons, subtended by a pathogenic process similar
to that causing pain at tender points [32]. Reduced habitu-
ation to pain, common to migraine and FM [10], may
Table 3 Clinical characteristics
of the primary headache types
Means and standard deviations
of clinical variables in primary
headaches types
Primary headache type Age
(years)
M (SD)
Duration
(years)
M (SD)
Frequency
(days/headache/
month)
M (SD)
Sex
(no.)
Chronic migraine cod.1.5.1 41.82 (13.36) 17.67 (13.61) 24.16 (6.45) M 19
F 122
Chronic tension-type headache cod 2.3 45.81 (15.60) 11 (12.4) 23.13 (6.51) M 31
F6 6
Cluster headache cod 3.1 41 (9.89) 17.8 (14.71) 13.8 (8.13) M 9
F4
Episodic frequent tension type headache
cod 2.2
41.6 (15.6) 11.6 (13) 5.5 (3.2) M 14
F4 1
Hemicrania continua cod 4.7 49.61 (15.86) 11.3 (11) 28.5 (1.21) M 2
F1 1
Migraine with aura cod 1.2 36.4 (11.26) 13.7 (9) 1.8 (1.12) M 6
F1 4
Migraine with aura plus migraine
without aura cod 1.1 plus 1.2
35.56 (11.71) 18.25 (13.20) 8.4 (7.5) M 7
F3 4
Migraine without aura cod 1.1 37.26 (12.56) 13.7 (9) 5.41 (3.2) M 96
F 336
Migraine without aura plus frequent
episodic tension type headache cod 1.1
plus 2.2
39.71 (13.38) 17.8 (11.9) 8.4 (7.2) M 8
F3 4
Mixed headache types
Primary stabbing headache no. 7 cod 4.1 37 (14.98) 7.7 (9) 8.4 (8.91) M 7
F1 7 Primary thunderclap headache no.
1cod 4.6
Hypnic headache no. 8 cod 4.5
Primary cough headache no. 4 cod 4.2
Primary exertional headache no. 3 cod 4.3
Paroxysmal hemicrania cod 3.2 43.5 (13.2) 9.9 (9.8) 19.4 (11.3) M 5
F6
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123facilitate central sensitization and myofascial pain persis-
tence in the presence of other favouring conditions such as
anxiety and sleep disturbances. A self-outstanding circuit of
increased headache frequency, development of pericranial
myofascial pain, persisting central sensitization with
somatic diffusion of pain, may explain FM comorbidity in
both chronic tension-type headache and chronic migraine,
where the persistence of pericranial tenderness contributes
to the transformation from episodic into chronic form [40].
Sleep disturbance is a well-recognized factor in FM syn-
drome [35], and our results conﬁrm that in headache
patients it favours generalized myofascial pain. The total
numbers of sleep hours were not dissimilar between FM and
non-FM patients, while the quality of sleep was the dis-
criminating factor for FM in our headache series, in accord
with our previous reports [7]. Clinical and preclinical data
concur that sleep disruption causes hyperalgesia, and
despite widely distributed and overlapping neural networks,
Table 4 Clinical features of
ﬁbromyalgic patients
Clinical variables introduced in
the multivariate analysis to
compare headache patients with
and without ﬁbromyalgia (FM)
comorbidity. The least
signiﬁcant difference (LSD)
was beyond the 0.05 level for all
variables except for allodynia
and SLPQ items
Dependent variable Mean Lower bound Upper bound
Age
No FM 37.291 36.192 38.390
FM 45.662 43.429 47.894
Duration
No FM 14.934 13.866 16.001
FM 18.035 15.866 20.203
Frequency
No FM 19.354 17.769 20.938
FM 28.428 25.211 29.645
MIDAS
No FM 33.882 30.032 37.733
FM 51.992 44.174 59.810
Allodynia
No FM 3.390 3.057 3.723
FM 4.108 3.432 4.783
TTS
No FM 4.187 3.710 4.663
FM 9.992 9.025 10.960
MAF
No FM 49.433 46.458 52.408
FM 77.500 71.459 83.541
SAS
No FM 40.170 39.459 40.880
FM 48.462 47.019 49.904
SDS
No FM 38.780 38.020 39.540
FM 45.754 44.210 47.298
ISF
No FM 42.623 41.856 43.390
FM 37.085 35.528 38.641
ISM
No FM 42.153 41.200 43.106
FM 36.469 34.533 38.405
SLP9
No FM 33.116 30.708 35.524
FM 53.631 47.715 59.547
SLPQ
No FM 6.503 6.328 6.677
FM 6.107 5.678 6.536
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123regulate states of sleep and pain; and the brain mechanisms
through which sleep and pain interact, remain poorly
understood [41, 42]. There is an intriguing hypothesis that
sleep deprivation decreases the analgesic effect of distrac-
tion in healthy individuals [43], and in the case of migraine,
it may accentuate the pattern of altered pain modulation
under distracting factors [44]. There are also evidences that
rapid eye movement (REM) sleep deprivation is especially
linked to hyperalgesia [45]. A signiﬁcant association
between severe sleep disturbances and chronic headache
[46, 47] and central sensitization [48] has further been
reported. Poor quality of sleep promotes diffusion of myo-
fascial pain in headache patients, but which sleep phase is
more involved in the generation of widespread pain remains
to be clariﬁed. Despite FM patients exhibiting higher
depression and anxiety levels, it was the latter feature that
best discriminated patients with diffuse pain among our
headache population. Mongini et al. [49] found that the
presence of anxiety considerably increases the level of
muscle tenderness in the head and, even more, in the neck,
and might facilitate the evolution into chronic headache
forms. In this way, anxiety may also facilitate diffuse
myofascial pain and FM comorbidity in headache patients
presenting with higher pericranial muscle tenderness. FM
patients were also characterized by a reduced functioning in
daily living, inherent to physical abilities. This may suggest
that persisting pericranial and somatic myofascial pain have
a consequence on motor performances and that physical
inability mainly compromise quality of life in patients
sharing FM comorbidity. A combination of symptoms is
needed to favour FM comorbidity, headache frequency
being the main, though not the only cause. In fact, other
primary headache types such as cluster headache, hemi-
crania continua, or parossistic migraine presented with high
headache frequency and low probability do match the
clinical proﬁle of FM patients. However, the low number of
patients included in these types of primary headaches
deserves further conﬁrmation in a larger series. Purely MA
patients presented with the lowest probability to share the
FM proﬁle, while the combination with migraine attacks not
preceded by aura symptoms conditioned higher represen-
tation of features facilitating diffuse somatic pain. Tietjen
et al. [28] recently found that the presence of aura did not
preserve the patients from FM comorbidity who were
Table 5 Classiﬁcation function coefﬁcients
No FM FM
Frequency 0.082 0.102
SAS 0.865 0.928
TTS 0.052 0.301
SLP9 -0.03 -0.002
PCF 0.891 0.831
Constant -37.382 -41.132
Fisher’s linear discriminant functions
Discriminating variables between ﬁbromyalgic (FM) and not ﬁ-
bromyalgic patients
SAS self-rating-anxiety-scale, TTS total tenderness score, SLP9 sleep
problems index, PCF physical component summary
6,25
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5,25
4,75
4,25
3,75
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DISCRIMINANT ANALYSIS FOR FIBROMYALGIA COMORBIDITY
Fig. 1 The ﬁgure summarizes the classiﬁcation of non-ﬁbromyalgic
and ﬁbromyalgic headache patients, according to the discriminating
factor derived from the best separating variables (frequency of
headache, self-rating anxiety scale, total tenderness score, sleep
problems index, physical component summary)
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123presenting with both types of migraine. Acute central sen-
sitization phenomena were ﬁrstly described as a develop-
ment of migraine aura [50] and allodynia has been
conﬁrmed a usual symptom in this type of migraine [28].
Moreover, acutely occurring allodynia does not account for
FM comorbidity, which is present when central sensitiza-
tion persists outside attacks and determines pericranial
tenderness. This argument needs, in our opinion, further
evaluation to specify if the prevalent presence of aura
characterizes a migraine phenotype with low predisposition
to chronic pain.
According to the previous report [7], headache severity
concurs with FM gravity, as expressed by the positive
correlation between the MIDAS and the impact of FM on
life functions. Although the ﬁndings reported by Marcus
et al. [8] did not support headache as an aggravating factor
for FM, our data conﬁrm that when headache is present its
severity is linked to an increase in expression of FM
symptoms. Our cases probably represent a subpopulation
among FM patients, reporting headache as the most rele-
vant problem, though in our opinion the relevance of
headache features deserves much attention in FM series,
for the large frequency of this symptom [35]. Allodynia
expressed during acute headache, correlated with the
invalidity linked with diffuse pain. This correlation may
suggest that the central sensitization phenomena occurring
during headache may also worsen the sufferance linked
with ﬁbromyalgic pain. An increased activation of the
nociceptive system at central level may be a generalized
phenomenon explaining a more severe impairment derived
from diffuse muscle-skeletal pain. In future studies, it
would be interesting to evaluate if the transformation of
headache into whole-body allodynia/hyperalgesia during a
migraine attack, mediated by sensitization of thalamic
neurons, may be an aggravating factor for FM [51].The
degree of evoked pain at tender points, was correlated with
pericranial tenderness, conﬁrming that both symptoms are
subtended by analogous mechanisms of muscular hyper-
algesia [32]. Frequency of headache seemed to concur with
augmented pain evoked at tender points, suggesting that a
generalized increment of pain sensitivity may develop with
the increase in headache occurrence [36]. A more robust
correlation should be conﬁrmed in larger multi-centre
studies.
Fig. 2 Probabilities (mean ± standard error) of membership to FM
groups for patients included in headache types (CM chronic migraine,
MA migraine with aura, MWA migraine without aura, CTH chronic
tension-type headache, ETH episodic tension-type headache, HC
hemicrania continua, HP paroxysmal hemicrania), according to the
discriminating function. The results of Bonferroni test, revealed that
CM and CTH groups signiﬁcantly differed from the others (p\0.01),
for the highest probability to share the FM proﬁle, while MA differed
from the others for the lowest probability (p\0.05)
Table 6 Correlation between
ﬁbromyalgia and headache
indices of severity in the 174
patients presenting with
ﬁbromyalgia comorbidity
FIQ Fibromyalgia Impact
Questionnaire TTS total
tenderness score
Frequency MIDAS Allodynia TTS
FIQ
Pearson correlation 0.289 0.215 0.349 0.065
Sig. (two-tailed) 0.001 0.014 0.000 0.467
Tender point survey
Pearson correlation 0.186 0.036 0.163 0.405
Sig. (two-tailed) 0.03 0.683 0.052 0.000
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123Conclusions
The overall consideration derived from the present data, is
that the evaluation of FM comorbidity may increase the
knowledge about the basic mechanisms of chronicization
and the expression of central sensitization phenomena in
the different primary headache subtypes. Though we have
to acknowledge the weakness of the study, being conducted
in a single tertiary referral centre, not representing the
general population, the detection of a phenotypic proﬁle,
where headache frequency concurs with anxiety, sleep
disturbance, and pericranial tenderness would be useful in
the management of diffuse pain and physical invalidity
development.
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